Julie Hepburn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julie Hepburn has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Edwards
School of Medicine, Cardiff University, Cardiff, UK
3 shared publications - Alison Cooper
Cardiff University
2 shared publications - Aloysius Niroshan Siriwardena
Community and Health Research Unit, University of Lincoln, Lincoln, UK
1 shared publication - Andrew Carson-Stevens
Division of Population Medicine, Cardiff University School of Medicine, Cardiff, Wales, United Kingdom
1 shared publication - Andrew Cunningham
Swansea University
1 shared publication - Barbara Harrington
PRIME Centre Wales, Cardiff University School of Medicine, Cardiff, Wales
1 shared publication
Latest Publications
- Open Access
- 19 November 2026
- Published by MDPI AG in Preprints.org
Learnings from Healthcare Systems with Large Reductions in Cancer Mortality: A Rapid Evidence Summary
In Wales, cancer is responsible for more than one in four deaths. The incidence of cancer is on the rise and it is projected that by 2035, there will be approximately 24,000 new cancer cases each year in Wales compared to approximately 20,000 in 2019. A new 10-year National Cancer Strategy for Wales will be announced in February 2027. This document was produced to gather learnings from other countries that have achieved improved cancer outcomes in recent years, to support the development of the strategy.The aim of this rapid evidence summary was to identify and describe structures and processes implemented at a national or regional level in countries that have significantly improved cancer outcomes in recent years.This rapid evidence summary consists of two parts. The first part summarised published evidence that directly linked cancer outcomes to country-level factors. Systematic searches of multiple academic and grey literature databases as well as supplementary searches were used to identify such evidence. The second part of this document reported learnings from countries with large reductions in mortality. Targeted searches for country-specific evidence were performed. Findings were summarised narratively.This rapid evidence summary identified only two studies linking relevant country-level factors, including healthcare system characteristics and characteristics of countries’ cancer plans and strategies, to cancer outcomes. To support the development of the new 10-year National Cancer Strategy for Wales, learnings from countries that have seen large improvements in cancer mortality over the recent years have been identified and summarised. While it is difficult to directly link improvements in cancer outcomes in a country to national cancer plans, we hope that examples of cancer-related activities in a wide range of countries that have successfully reduced mortality will provide useful learnings. Due to the high variation in the country contexts, considerations about the applicability to Wales need to be made. In the report, we also discuss the policy and practice implications of the findings, and the research implications and evidence gaps.
- 19 November 2026
- Published by MDPI AG in Preprints.org
Open AccessLearnings from Healthcare Systems with Large Reductions in Cancer Mortality: A Rapid Evidence Summary
In Wales, cancer is responsible for more than one in four deaths. The incidence of cancer is on the rise and it is projected that by 2035, there will be approximately 24,000 new cancer cases each year in Wales compared to approximately 20,000 in 2019. A new 10-year National Cancer Strategy for Wales will be announced in February 2027. This document was produced to gather learnings from other countries that have achieved improved cancer outcomes in recent years, to support the development of the strategy.The aim of this rapid evidence summary was to identify and describe structures and processes implemented at a national or regional level in countries that have significantly improved cancer outcomes in recent years.This rapid evidence summary consists of two parts. The first part summarised published evidence that directly linked cancer outcomes to country-level factors. Systematic searches of multiple academic and grey literature databases as well as supplementary searches were used to identify such evidence. The second part of this document reported learnings from countries with large reductions in mortality. Targeted searches for country-specific evidence were performed. Findings were summarised narratively.This rapid evidence summary identified only two studies linking relevant country-level factors, including healthcare system characteristics and characteristics of countries’ cancer plans and strategies, to cancer outcomes. To support the development of the new 10-year National Cancer Strategy for Wales, learnings from countries that have seen large improvements in cancer mortality over the recent years have been identified and summarised. While it is difficult to directly link improvements in cancer outcomes in a country to national cancer plans, we hope that examples of cancer-related activities in a wide range of countries that have successfully reduced mortality will provide useful learnings. Due to the high variation in the country contexts, considerations about the applicability to Wales need to be made. In the report, we also discuss the policy and practice implications of the findings, and the research implications and evidence gaps.
- Open Access
- 22 January 2022
- Published by Springer Nature in BMC Emergency Medicine
- Vol. 22 (1) , 1-12
Patients’ experiences of attending emergency departments where primary care services are located: qualitative findings from patient and clinician interviews from a realist evaluation
Background: Patient experience is an important outcome and indicator of healthcare quality, and patient reported experiences are key to improving quality of care. While patient experience in emergency departments (EDs) has been reported in research, there is limited evidence about patients’ specific experiences with primary care services located in or alongside EDs. We aim to identify theories about patient experience and acceptability of being streamed to a primary care clinician in an ED.Methods: Using theories from a rapid realist review as a basis, we interviewed 24 patients and 106 staff members to generate updated theories about patient experience and acceptability of streaming to primary care services in EDs. Feedback from 56 stakeholders, including clinicians, policymakers and patient and public members, as well as observations at 13 EDs, also contributed to the development of these theories, which we present as a programme theory.Results: We found that patients had no expectations or preferences for which type of clinician they were seen by, and generally found being streamed to a primary care clinician in the ED acceptable. Clinicians and patients reported that patients generally found primary care streaming acceptable if they felt their complaint was dealt with suitably, in a timely manner, and when clinicians clearly communicated the need for investigations, and how these contributed to decision-making and treatment plans.Conclusions: From our findings, we have developed a programme theory to demonstrate that service providers can expect that patients will be generally satisfied with their experience of being streamed to, and seen by, primary care clinicians working in these services. Service providers should consider the potential advantages and disadvantages of implementing primary care services at their ED. If primary care services are implemented, clear communication is needed between staff and patients, and patient feedback should be sought.
- 22 January 2022
- Published by Springer Nature in BMC Emergency Medicine
- Vol. 22 (1) , 1-12
Open AccessPatients’ experiences of attending emergency departments where primary care services are located: qualitative findings from patient and clinician interviews from a realist evaluation
Background: Patient experience is an important outcome and indicator of healthcare quality, and patient reported experiences are key to improving quality of care. While patient experience in emergency departments (EDs) has been reported in research, there is limited evidence about patients’ specific experiences with primary care services located in or alongside EDs. We aim to identify theories about patient experience and acceptability of being streamed to a primary care clinician in an ED.Methods: Using theories from a rapid realist review as a basis, we interviewed 24 patients and 106 staff members to generate updated theories about patient experience and acceptability of streaming to primary care services in EDs. Feedback from 56 stakeholders, including clinicians, policymakers and patient and public members, as well as observations at 13 EDs, also contributed to the development of these theories, which we present as a programme theory.Results: We found that patients had no expectations or preferences for which type of clinician they were seen by, and generally found being streamed to a primary care clinician in the ED acceptable. Clinicians and patients reported that patients generally found primary care streaming acceptable if they felt their complaint was dealt with suitably, in a timely manner, and when clinicians clearly communicated the need for investigations, and how these contributed to decision-making and treatment plans.Conclusions: From our findings, we have developed a programme theory to demonstrate that service providers can expect that patients will be generally satisfied with their experience of being streamed to, and seen by, primary care clinicians working in these services. Service providers should consider the potential advantages and disadvantages of implementing primary care services at their ED. If primary care services are implemented, clear communication is needed between staff and patients, and patient feedback should be sought.
- Open Access
A new method to triage colorectal cancer referrals in the UK using serum Raman spectroscopy and machine learning
Suspected colorectal cancer (CRC) referrals based on non-specific symptoms currently lead to large numbers of patients being referred for invasive investigations and poor yield in cancer detection. Secondary care diagnostics, particularly endoscopy, struggle to meet the ever-increasing demand and patients face lengthy waits from the point of referral. Here we propose a blood test utilising high-throughput Raman spectroscopy and machine learning as an accurate triage tool. We present results from the first mixed methods clinical validation study of its kind, evaluating the ability of the test to perform in its target population of primary care patients, and its acceptability to those administering and receiving the test. The test was able to accurately rule out cancer with a negative predictive value of 98.0%. This performance could reduce the number of invasive diagnostic procedures in the cohort by at least 47%. Collectively, our findings promote a novel, non-invasive solution to triage CRC referrals with potential to reduce patient anxiety, accelerate access to treatment and improve outcomes.
Open AccessA new method to triage colorectal cancer referrals in the UK using serum Raman spectroscopy and machine learning
Suspected colorectal cancer (CRC) referrals based on non-specific symptoms currently lead to large numbers of patients being referred for invasive investigations and poor yield in cancer detection. Secondary care diagnostics, particularly endoscopy, struggle to meet the ever-increasing demand and patients face lengthy waits from the point of referral. Here we propose a blood test utilising high-throughput Raman spectroscopy and machine learning as an accurate triage tool. We present results from the first mixed methods clinical validation study of its kind, evaluating the ability of the test to perform in its target population of primary care patients, and its acceptability to those administering and receiving the test. The test was able to accurately rule out cancer with a negative predictive value of 98.0%. This performance could reduce the number of invasive diagnostic procedures in the cohort by at least 47%. Collectively, our findings promote a novel, non-invasive solution to triage CRC referrals with potential to reduce patient anxiety, accelerate access to treatment and improve outcomes.
- Open Access
- 11 March 2019
- Published by Springer Nature in BMC Public Health
- Vol. 19 (1) , 285
Improving cancer symptom awareness and help-seeking among adults living in socioeconomically deprived communities in the UK using a facilitated health check: A protocol for the Awareness and Beliefs About Cancer (ABACus) Randomised Control Trial
Cancer survival is lower in socioeconomically deprived communities, partly due to low awareness of symptoms, negative beliefs and delayed help-seeking. We developed an interactive health check questionnaire facilitated by trained lay advisors. It entails 29 questions about background, lifestyle and health with tailored behaviour change advice. Personalised results are printed using a traffic light (red/amber/green) system, highlighting areas where action should be taken. This is an individually randomised control trial to test effectiveness of the health check on symptom recognition. A total 246 participants aged 40+ years will be recruited from community and healthcare settings in socioeconomically deprived areas of Yorkshire and South Wales. Participants will be randomised to receive the health check or standard care (1:1 ratio). Outcome measures include: adapted Awareness and Beliefs about Cancer (primary outcome), brief State Trait Anxiety Inventory, intentions and motivation to adopt recommended health behaviours (early symptom presentation, cancer screening and lifestyle behaviours), adapted Client Service Receipt Inventory, brief medical history/screening and demographic questionnaire at: baseline; 2-weeks; and 6-months post-randomisation. A purposive sample of intervention sessions will be audio-recorded (n = 24) and half will additionally be observed (n = 12). Semi-structured interviews will take place at 2-weeks (n = 30) and 6-months (n = 15–20) post-randomisation. The primary analysis will compare cancer symptom recognition scores between arms at 2-weeks. Secondary analysis will assess cancer beliefs, barriers/time to presentation, screening and lifestyle behaviours, anxiety and costs. A process evaluation will assess intervention fidelity, dose and contamination. The London-Surrey NHS Research Ethics Committee (Ref: 17/LO/1507) approved this trial. This is a trial of a theoretically underpinned complex intervention which has undergone phase 1 and 2 development work. The findings will evaluate evidence about the effect of the health check on symptom awareness. Although there are few exclusion criteria there are limitations regarding the population we are able to reach, who may have even higher risks of late diagnosis and poor cancer prognosis. However, the health check has the potential to improve cancer symptom awareness and encourage early help-seeking behaviour in deprived populations, thereby reducing inequalities in longer term cancer outcomes. Retrospectively registered with ISRCTN (Ref: ISRCTN16872545 ) on 12.01.2018.
- 11 March 2019
- Published by Springer Nature in BMC Public Health
- Vol. 19 (1) , 285
Open AccessImproving cancer symptom awareness and help-seeking among adults living in socioeconomically deprived communities in the UK using a facilitated health check: A protocol for the Awareness and Beliefs About Cancer (ABACus) Randomised Control Trial
Cancer survival is lower in socioeconomically deprived communities, partly due to low awareness of symptoms, negative beliefs and delayed help-seeking. We developed an interactive health check questionnaire facilitated by trained lay advisors. It entails 29 questions about background, lifestyle and health with tailored behaviour change advice. Personalised results are printed using a traffic light (red/amber/green) system, highlighting areas where action should be taken. This is an individually randomised control trial to test effectiveness of the health check on symptom recognition. A total 246 participants aged 40+ years will be recruited from community and healthcare settings in socioeconomically deprived areas of Yorkshire and South Wales. Participants will be randomised to receive the health check or standard care (1:1 ratio). Outcome measures include: adapted Awareness and Beliefs about Cancer (primary outcome), brief State Trait Anxiety Inventory, intentions and motivation to adopt recommended health behaviours (early symptom presentation, cancer screening and lifestyle behaviours), adapted Client Service Receipt Inventory, brief medical history/screening and demographic questionnaire at: baseline; 2-weeks; and 6-months post-randomisation. A purposive sample of intervention sessions will be audio-recorded (n = 24) and half will additionally be observed (n = 12). Semi-structured interviews will take place at 2-weeks (n = 30) and 6-months (n = 15–20) post-randomisation. The primary analysis will compare cancer symptom recognition scores between arms at 2-weeks. Secondary analysis will assess cancer beliefs, barriers/time to presentation, screening and lifestyle behaviours, anxiety and costs. A process evaluation will assess intervention fidelity, dose and contamination. The London-Surrey NHS Research Ethics Committee (Ref: 17/LO/1507) approved this trial. This is a trial of a theoretically underpinned complex intervention which has undergone phase 1 and 2 development work. The findings will evaluate evidence about the effect of the health check on symptom awareness. Although there are few exclusion criteria there are limitations regarding the population we are able to reach, who may have even higher risks of late diagnosis and poor cancer prognosis. However, the health check has the potential to improve cancer symptom awareness and encourage early help-seeking behaviour in deprived populations, thereby reducing inequalities in longer term cancer outcomes. Retrospectively registered with ISRCTN (Ref: ISRCTN16872545 ) on 12.01.2018.